The aim is to explore the effects of imeglimin on insulin secretion and sensitivity in patients with type 2 diabetes.
Analysis of insulin dynamics during treatment with imeglimin
Assessment of insulin sensitivity parameters
Comparative evaluation against control group
Imeglimin enhanced insulin secretion in response to glucose
Improved insulin sensitivity was observed among participants
Both effects contributed positively to glycemic control
Abstract
The cover image is based on the article Dual action of imeglimin on insulin secretion and sensitivity in type 2 diabetes by Tsubasa Tajima MD et al., https://doi.org/10.1111/dom.70449 . image